FDA Acts To Stem Shortages Of Cancer Drugs Doxil And Methotrexate
Doxil, a cancer drug from Johnson & Johnson, has been in persistent short supply since manufacturing problems surfaced at
fda act stem shortages cancer dr USA doxil methotrexate doxil cancer drug johnson johnson persistent short supply manufacturing problem surface